In the context of cancer, vasoconstriction can significantly influence the tumor microenvironment and the efficacy of cancer treatments. Tumors often exhibit abnormal blood vessel growth, known as angiogenesis, which can lead to disorganized and inefficient blood flow. Vasoconstriction can exacerbate these issues by further restricting blood supply to the tumor, potentially affecting the delivery of chemotherapy and immunotherapy agents.
